透過您的圖書館登入
IP:216.73.216.74
  • 學位論文

以生物可分解聚乳酸為基材之複合材料系統之植入物與生物支架之研發

The research and development of biodegradable polylactic acid based composite materials for implant and scaffold applications

指導教授 : 方旭偉
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


聚乳酸因為其生物可分解性、生物可吸收性及生物相容性的性質,已經被廣泛的運用在生物醫學上。如骨釘、骨板、可吸收手術縫合線及骨填補支架。然而因為其無法獨立控制的問題,如若需要骨釘則機械強度就要高,聚乳酸分子量就會大,那麼其分解速率就會相對的變慢。 因此,如何獨立控制聚乳酸的機械強度及分解速率就是我們要研究的課題。文獻上指出聚乳酸加入氫氧基磷灰石或三鈣磷酸鹽有助於骨母細胞的生長;而加入聚丙烯碳酸酯則是可以降低其玻璃轉移溫度(Tg),使得材料變得較有彈性。 在本研究中,我們將利用溶劑混合法及鹽析法將氫氧基磷灰石、三鈣磷酸鹽或聚丙烯碳酸酯與聚乳酸混合去研發出以聚乳酸為基材的複合材料。而研究結果顯示出,我們因為氫氧基磷灰石、三鈣磷酸鹽或聚丙烯碳酸酯的含量不同,其機械性質與分解速率也有顯著的不同,這證明了我們可以獨立控制聚乳酸複合材料的機械性質與分解速率;我們也利用鹽析法成功的研發出無溶劑殘留的多孔性聚乳酸複合材料;最後我們使得聚乳酸複合材料具有較高的彈性度,並在室溫下我們就可以像橡皮擦一樣的任意改變其形狀;而臨床前動物試驗的結果也顯示出聚乳酸複合材料的生物相容性及有助於骨母細胞生長的特性。此研究成果讓幫助我們找出聚乳酸複合材料對於特定醫學應用上配方的最佳化,而這也有助於我們將來在聚乳酸複合材料商品化的推廣。

並列摘要


Polylactic acid (PLA) materials have been used in biomedical applications such as bone screws, sutures, and scaffold materials because they are biodegradable, bioresorbable, and biocompatible. There is an increasing need to achieve independent control of key properties such as mechanical strength, degradation rate, and bioactivity in order to further enhance the performance of PLA-based medical implants. Because PLA composites containing hydroxyapatite (HAp) or tricalcium phosphate (TCP) particles can augment cell growth and mechanical properties, PLA composites containing polypropylene carbonate (PPC) can decrease the value of the glass transition temperature Tg, which makes the PLA composites flexible. Hence, in this study, we use a solvent mix method and a non-solvent salt leaching method to fabricate PLA-based composite materials with hydroxyapatite (HAp), tricalcium phosphate (TCP), or polypropylene carbonate (PPC). The resultant properties of the PLA-based composite materials show that we can control the mechanical properties and degradation rate of these materials independently, turn them into porous composites, make them relatively elastic, and change their shape at room temperature; one example of such a material is an eraser. A pre-clinical study (animal study) proves the biocompatibility of PLA composite materials. This can help us to promote the commercialization of PLA composite materials quickly. The information resulting from this study can assist in the optimization of PLA composite formulas for specific medical applications.

參考文獻


[1] Vainionpaa S, Rokkanen P, Tormaala P, Prog. Surgical applications of biodegradable polymers in human tissues. Progress in Polymer Science 1989;14:679-716.
[3] Rokkanen P. Absorbable materials in orthopaedic surgery. Annals of Medicine 1991;23(2):109-15.
[4] Shikinami Y, Okuno M. Bioresorbable devices made of forged composites of hydroxyapatite (HA) particles and poly-L-lactide (PLLA): Part I. Basic characteristics. Biomaterials 1999;20(9):859-77.
[5] Mainil P, Curtis R, Gogolewski S. Effect of in vivo and in vitro degradation on molecular and mechanical properties of various low-molecular-weight polylactides. Journal of Biomedical Materials Research 1997;36(3):360-80.
[7] Kasuga T, Ota Y, Nogami M, Abe Y. Preparation and mechanical properties of polylactic acid composites containing hydroxyapatite fibers. Biomaterials 2001;22(1):19-23.

延伸閱讀